These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10217912

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
    Bird TD, Kraft GH, Lipe HP, Kenney KL, Sumi SM.
    Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
    [Abstract] [Full Text] [Related]

  • 29. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
    Uno S, Katayama K, Dobashi N, Hirano A, Ogihara A, Yamazaki H, Usui N, Kobayashi T, Inoue K, Kuraishi Y.
    Rinsho Ketsueki; 1999 May; 40(5):414-9. PubMed ID: 10390891
    [Abstract] [Full Text] [Related]

  • 30. Molecular genetics of hereditary neuropathies.
    Chance PF.
    J Child Neurol; 1999 Jan; 14(1):43-52. PubMed ID: 10223854
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
    Sevilla T, Lupo V, Martínez-Rubio D, Sancho P, Sivera R, Chumillas MJ, García-Romero M, Pascual-Pascual SI, Muelas N, Dopazo J, Vílchez JJ, Palau F, Espinós C.
    Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Charcot-Marie-Tooth disease disclosed by a treatment with vincristine in familial Hodgkin's disease].
    Geny C, Gaio JM, Mallaret M, Goy A, Reymond F, Pegourie B, Yulis J, Perret JE.
    Ann Med Interne (Paris); 1990 Jan; 141(8):709-10. PubMed ID: 2091516
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Uneventful administration of vincristine in Charcot-Marie-Tooth disease type 1X.
    Ajitsaria R, Reilly M, Anderson J.
    Pediatr Blood Cancer; 2008 Apr; 50(4):874-6. PubMed ID: 17514737
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.